5-Substituted quinazolinone derivatives and compositions...

Details 5-Substituted quinazolinone derivatives and compositions... 5-Substituted quinazolinone derivatives and compositions...

2007-09-26

2009-12-22

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S287000, C546S189000, C546S348000

Reexamination Certificate

active

07635700

ABSTRACT:
Provided are 5-substituted quinazolinone compounds, for example, of formula (I), and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use for treating angiogenesis or cytokine related disorders, and pharmaceutical compositions of these compounds are disclosed.

REFERENCES:
patent: 5635517 (1997-06-01), Muller et al.
patent: 2003/0199530 (2003-10-01), Goldstein et al.
patent: WO 2004/103274 (2004-12-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
Dörwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
El-Fattah et al., “Synthesis and screening of some quinazolinone derivatives,” Bulletin of the Faculty of Pharmacy, Cairo University, 15:273-283 (1976).
Jonsson et al., “Chemical structure and teratogenic properties,”Acta Pharm. Suecica, 9:431-446 (1972).

Affiliated with

Also associated with

Rating

5-Substituted quinazolinone derivatives and compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-Substituted quinazolinone derivatives and compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Substituted quinazolinone derivatives and compositions... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4123821